Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – A study published today provides more evidence that proton pump inhibitors (PPI) interfere with clopidogrel. Recommendations from the Society for Cardiovascular Angiography and…
NEW YORK (Reuters Health) – Patients with vascular dementia who took the acetylcholinesterase inhibitor donepezil had mild improvements in cognitive function, but not global function, in an international…
NEW YORK (Reuters Health) – The TNF alpha inhibitor adalimumab provides minor analgesia in patients with radicular pain due to lumbar disc herniation, but prompts a major reduction…
NEW YORK (Reuters Health) – For patients with acute kidney injury, increasing the intensity of hemodialysis over recommended levels does not reduce mortality or improve renal recovery, according…
NEW YORK (Reuters Health) – Physicians should monitor serum testosterone levels during androgen-deprivation therapy (ADT) in men with prostate cancer, according to an April 16th online report in…
NEW YORK (Reuters Health) – Using recombinant tissue plasminogen activator (rtPA) within existing licensing limits is fully justified by available data – but there’s not enough data to…
NEW YORK (Reuters Health) – The angiotensin II receptor blocker olmesartan medoxomil (Benicar) significantly reduces blood pressure in children with primary or secondary hypertension, according to an international…
NEW YORK (Reuters Health) – Despite the popularity of urethrotomy for treating urethral strictures in men, the success rate is less than 10% initially and may drop to…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate (MgSO4) does not benefit patients with acute aneurysmal subarachnoid hemorrhage, according to results of a phase III trial. In the…
Get a real-life look at what’s happening on the ground in Haiti from Dr. Pierre Rouzier, Sports Medicine doctor at University of Massachusetts Amherst. In the aftermath of…
